Mechanism of the protective effect of yulangsan flavonoid on myocardial ischemia/reperfusion injury in rats

Cellular Physiology and Biochemistry

Volumn 34, Issue 4, 2014, Pages 1050-1062

  Zhang, Xudong ^a,b   Liang, Xingmei ^a   Lin, Xing ^a   Zhang, Shijun ^a   Huang, Zhongshi ^a   Chen, Chunxia ^a   Guo, Youjia ^a   Xuan, Feifei ^a   Xu, Xiaohui ^a   Huang, Renbin ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

^b MUDANJIANG MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Lipid peroxidation; MI RI; NOS; YLSF

Indexed keywords

ADENINE NUCLEOTIDE TRANSLOCASE; ASPARTATE AMINOTRANSFERASE; CARDIAC AGENT; CASPASE 3; CREATINE KINASE MB; DILTIAZEM; FLAVONOID; GLUTATHIONE PEROXIDASE; INDUCIBLE NITRIC OXIDE SYNTHASE; LACTATE DEHYDROGENASE; MALONALDEHYDE; MESSENGER RNA; NITRIC OXIDE SYNTHASE; PROTECTIVE AGENT; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; YULANGSAN FLAVONOID; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CELL INFILTRATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HISTOPATHOLOGY; INFLAMMATORY CELL; LACTATE DEHYDROGENASE BLOOD LEVEL; LIPID PEROXIDATION; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; ANIMAL; DRUG EFFECTS; HEART; HEART MUSCLE; METABOLISM; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY;

ANIMALS; CASPASE 3; FLAVONOIDS; HEART; LIPID PEROXIDATION; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84908622589     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000366320     Document Type: Article

References (45)

1. Sekikawa A, Horiuchi BY, Edmundowicz D, Ueshima H, Curb JD, Sutton-Tyrrell K, Okamura T, Kadowaki T, Kashiwagi A, Mitsunami K, Murata K, Nakamura Y, Rodriguez BL, Kuller LH: A "natural experiment" in cardiovascular epidemiology in the early 21st century. Heart 2003;89:255-257.
2. Jennings RB, Sommers HM, Smyth GA, Flack HA,LinnI H: Myocardial necrosis induced by temporary occlusion of a coronary artery in the dog. Arch Pathol 1960;70:68-78.
3. Lee YM, Cheng PY, Chen SY, Chung MT, Sheu JR: Wogonin suppresses arrhythmias, inflammatory responses, and apoptosis induced by myocardial ischemia/reperfusion in rats. J Cardiovasc Pharm 2011;58:133-142.
4. Soloviev A, Stefanov A, Parshikov A, Khromov A, Moibenko A, Kvotchina L, Balavoine G, Geletii Y: Arrhythmogenic peroxynitrite-induced alterations in mammalian heart contractility and its prevention with quercetin-filled liposomes. Cardiovasc Toxicol 2002;2:129-139.
5. Bishopric NH, Andreka P, Slepak T, Webster KA: Molecular mechanisms of apoptosis in the cardiac myocyte. Curr Opin Pharmacol 2001;1:141-150.
6. Gustafsson AB, Gottlieb RA: Mechanisms of apoptosis in the heart. J Clin Immunol 2003;23:447-459.
7. Bruegger D, Rehm M, Jacob M, Chappel D, Stoeckelhuber M, Welsch U, Conzen P, Becker BF: Exogenous nitric oxide requires an endothelial glycocalyx to prevent postischemic coronary vascular leak in guinea pig hearts. Crit Care 2008;12:73.
8. Hirai DM, Copp SW, Ferreira LF, Musch TI, Poole DC: Nitric oxide bioavailability modulates the dynamics of microvascular oxygen exchange during recovery from contractions. ACTA Physiol 2010;200:159-169.
9. Moncada S, Palmer RM, Higgs EA: Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109-142.
10. Förstermann U, Closs EI, Pollock JS, Nakane M, Schwarz P, Gath I, Kleinert H: Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions. Hypertension 1994;23:1121-1131.
11. McGowan FX Jr, Davis PJ, del Nido PJ, Sobek M, Allen JW, Downing SE: Endothelium-dependent regulation of coronary tone in the neonatal pig. Anesth Analg 1994;79:1094-1101.
12. Radomski MW, Palmer RM, Moncada S: The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Brit J Pharmacol 1987;92:639-646.
13. Kubes P, Suzuki M, Granger DN: Nitric oxide: an endogenous modulator of leukocyte adhesion. P Natl Acad Sci USA 1991;88:4651-4655.
14. Groves PH, Lewis MJ, Cheadle HA, Penny WJ: SIN-1 reduces platelet adhesion and platelet thrombus formation in a porcine model of balloon angioplasty. Circulation 1993;87:590-597.
15. Radomski MW, Palmer RM, Moncada S: Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 1987;2:1057-1058.
16. Kim YM, Bombeck CA, Billiar TR: Nitric oxide as a bifunctional regulator of apoptosis. Circ Res 1999;84:253-256.
17. Brunner F, Maier R, Andrew P, Wölkart G, Zechner R, Mayer B: Attenuation of myocardial ischemia/ reperfusion injury in mice with myocyte-specific overexpression of endothelial nitric oxide synthase. Cardiovasc Res 2003;57:55-62.
18. Department of Health of Guangxi Zhuang Autonomous Region: Guangxi Chinese medicine standard. Guangxi Science and Technology Press. 1992, vol 35.
19. Huang XC, Zhou ZC, Zhang J: Guangxi national medicine compendium. Guangxi Institute for Drug Control 1980, vol 134.
20. Zhang XD, Jiang WZ, Jiao Y, Huang RB: The Study of Longyanshen Flavonoids on Anti- lipid Peroxidation Injury Induced by Myocardial Ischemia Reperfusion in Rats. Lishizhen Med Mater Med Res 2008;19:607-609.
21. Huang RB, Lv JH, Zhang XD, Fv SJ, Jiao Y: Effects of Yulangsan flavonoids on myocardial ischemia reperfusion injury in isolated rat hearts. West China J Pharm Sci 2010;25:287-289.
22. Jian J, Huang JC, Jiao Y, Tan HD, Huang RB: Isolation and preparation of chalcone compounds from tuber of Millettia pulchra var. laxior by pre-HPLC. Chin Tradit Herb Drugs 2011;42:1313-1316.
23. Jy W, Yan N, Yang D-h: Electrocardiogram changes on myocardial ischenmia-reperfusion model in rats. South China J Cardiovasc Dis 2011;17:503-506.
24. Yellon DM, Hausenloy DJ: Myocardial reperfusion injury. N Engl J Med 2007;357:1121-1135.
25. Dhalla NS, Elmoselhi AB, Hata T, Makino N: Status of myocardial antioxidants in ischemia-reperfusion injury. Cardiovasc Res 2000;47:446-456.
26. Peterson DA, Asinger RW, Elsperger KJ, Homans DC, Eaton JW: Reactive oxygen species may cause myocardial reperfusion injury. Biochem Biophys Res Commun 1985;127:87-93.
27. Venardos KM, Perkins A, Headrick J, Kaye DM: Myocardial ischemia-reperfusion injury, antioxidant enzyme systems, and selenium: a review. Curr Med Chem 2007;14:1539-1549.
28. Kupatt C, Hinkel R, Horstkotte J, Deiss M, von Brühl ML, Bilzer M, Boekstegers P: Selective retroinfusion of GSH and cariporide attenuates myocardial ischemia-reperfusion injury in a preclinical pig model. Cardiovasc Res 2004;61:530-537.
29. Gürgün C, Ildizli M, Yavuzgil O, Sin A, Apaydin A, Cinar C, Kültürsay H: The effects of short term statin treatment on left ventricular function and inflammatory markers in patients with chronic heart failure. Int J Cardiol 2008;123:102-107.
30. Dörner A, Schulze K, Rauch U, Schultheiss HP: Adenine nucleotide translocator in dilated cardiomyopathy: pathophysiological alterations in expression and function. Mol Cell Biochem 1997;174:261-269.
31. Kirshenbaum LA, Singal PK: Changes in antioxidant enzymes in isolated cardiac myocytes subjected to hypoxia-reoxygenation. Lab Invest 1992;67:796-803.
32. Wang D, Yang XP, Liu YH, Carretero OA, Lapointe MC: Reduction of myocardial infarct size by inhibition of inducible nitric oxide synthase. Am J Hypertens 1999;12:174-182.
33. Saito T, Hu F, Tayara L, Fahas L, Shennib H, Giaid A: Inhibition of NOS II prevents cardiac dysfunction in myocardial infarction and congestive heart failure. Am J Physiol Heart Circ Physiol 2002;283:339-345.
34. Wildhirt SM1, Weismueller S, Schulze C, Conrad N, Kornberg A, Reichart B: Inducible nitric oxide synthase activation after ischemia/reperfusion contributes to myocardial dysfunction and extent of infarct size in rabbits: evidence for a late phase of nitric oxide-mediated reperfusion injury. Cardiovasc Res 1999;43:698-711.
35. Feng Q, Lu X, Jones D L, Shen J, Arnold JM: Increased inducible nitric oxide synthase expression contributes to myocardial dysfunction and higher mortality after myocardial infarction in mice. Circulation 2001;104:700-704.
36. Mehlhorn U, Bloch W, Krahwinkel A, LaRose K, Geissler HJ, Hekmat K, Addicks K, de Vivie ER: Activation of myocardial constitutive nitric oxide synthase during coronary artery surgery. Eur J Cardiothorac Surg 2000;17:305-11.
37. Zaitone SA, Abo-Gresha NM: Rosuvastatin promotes angiogenesis and reverses isoproterenol-induced acute myocardial infarction in rats: role of iNOS and VEGF. Eur J Pharmacol 2012;691:134-142.
38. Ma LL, Zhang FJ, Yan M: Sevoflurane preconditioning produces delayed cardioprotection effect through up-regulation of inducible nitric oxide synthase in rats. J Zhejiang Univ 2012;41:553-558.
39. Wang W, Sawichi G, Schulz R: Peroxynitrite-induced myocardial injury is mediated through matrix metalloproteinase-2. Cardiovasc Res 2002;53:165-174.
40. Doerner A, Pauschinger M, Badorff A, Noutsias M, Giessen S, Schulze K, Bilger J, Rauch U, Schultheiss HP: Tissue-specific transcription pattern of the adenine nucleotide translocase isoforms in humans. FEBS Lett 1997;414:258-262.
41. Dorner A, Olesch M, Giessen S, Pauschinger M, Schultheiss HP: Transcription of the adenine nucleotide translocase isoforms in various types of tissues in the rat. Biochim Biophys Acta 1999;1417:16-24.
42. Ning XH, Xu CS, Song YC, Xiao Y, Hu YJ, Lupinetti FM, Portman MA: Hypothermia preserves function and signaling for mitochondrial biogenesis during subsequent ischemia. Am J Physiol 1998;274:786-793.
43. Esposito LA, Melov S, Panov A, Cottrell BA, Wallace DC: Mitochondrial disease in mouse results in increased oxidative stress. Proc Natl Acad Sci USA 1999;96:4820-4825.
44. Lakhani SA, Masud A, Kuida K, Porter GA, Booth CJ, Mehal WZ, Inayat I, Flavell RA: Caspases 3 and 7: key mediators of mitochondrial events of apoptosis. Science 2006;311:847-851.
45. Hataishi R, Rodrigues AC, Neilan TG, Morgan JG, Buys E, Sshiva S, Tambouret R, Jassal DS, Raher MJ, Furutani E, Ichinose F, Gladwin MT, Rosenzweig A, Zapol WM, Picard MH, Bloch KD, Scherrer-Crosbie M: Inhaled nitric oxide decreases infarction size and improves left ventricular function in a murine model of myocardial ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 2006;291:379-384.